The environmental impact of weight-loss drugs

被引:0
作者
Pratap, Aayushi
机构
关键词
Environmental impact;
D O I
10.1021/cen-10213-feature1
中图分类号
学科分类号
摘要
Novo Nordisk is spending $6 billion in Kalundborg, Denmark, to expand the production of active pharmaceutical ingredients (APIs), including peptides used in weight-loss and antidiabetic drugs. The Danish company’s rival, Eli Lilly and Company, recently built a peptide synthesis plant in Kinsale, Ireland.
引用
收藏
页码:18 / 20
相关论文
empty
未找到相关数据